Abstract Body

Background:

We have previously reported on a temporal decrease in CD4 cell count at seroconversion (SC) and an increase in HIV-RNA viral load (VL) levels at 1 year (which we refer to as set-point) over the period 1980-2008. These markers of virulence reached a plateau in the mid 2000’s. Here we update these analyses, focusing on changes since the introduction of combination ART in 1996.

Methods:

Data were derived from the CASCADE Collaboration. Included individuals seroconverted ≥1996, were ≥16 years, had an HIV- to HIV+ test interval ≤1 year or other laboratory evidence of SC, and CD4/VL measurements while ART naïve and AIDS-free. Exploratory analysis revealed gradient changes at ~4 months and ~1 year after SC for CD4 and VL, respectively. Analyses were based on piecewise linear mixed models. Calendar time effects were introduced through natural cubic splines. For CD4 at 4 months after SC and viral set-point analyses, those seroconverting after 1/1/2015 and 1/1/2014, respectively, were excluded, as they tended to initiate ART very soon after SC and reliable estimation of these quantities was not feasible. Models were adjusted for age, sex, transmission mode, region of origin, acute infection (< or ≥30 day HIV test interval) and type of viral assay.

Results:

Of 28556 individuals in CASCADE, 15059 (52.7%) fulfilled the inclusion criteria. The majority (70.5%) acquired HIV through sex between men and 10.3% men and 14.3% women through heterosexual contact. Median (IQR) age at SC was 33 (27, 41) years. Of 2701 with known subtype 2275 (84.2%) had a B subtype. Estimated (95% CI) CD4 cell count levels at 4 months after SC declined from 598 (562-635) for those seroconverting in 1996, to a plateau of ~559 (530-588) cells/μl for those seroconverting between 2006 and 2010 and slowly increased in more recent years (Figure, a). Viral set-point showed a similar but reversed trend with an increase from 4.31 (4.17-4.44) in 1996 to ~ 4.47 (4.36-4.58) log c/mL in 2006-2010 and a slow declining trend thereafter (Figure, b). Individuals with CRF02_AG subtype had approximately 62 cells/μl lower CD4 cell count at 4 months after SC (p=0.023) and all non-B subtypes were associated with non-significantly lower viral set-point compared to those with B subtype.

Conclusions:

Our results showed minimal changes in levels of both CD4 soon after SC and viral set-point after 2004 suggesting that these markers of HIV virulence may have plateaued.